Tag : multiple sclerosis (ms)

Latest News

Commentary: What Neurologists Can Expect From COVID-19

Newsemia
A discussion with Dr Kenneth Tyler on the most likely neurologic implications of the virus, and how the field can respond to the crisis. Source...
Latest News

FDA Clears Ozanimod (Zeposia) for MS; COVID-19 Delays Launch

Newsemia
Ozanimod is the first oral, once-daily sphingosine-1-phosphate receptor modulator approved for adults with relapsing forms of multiple sclerosis. Source link...
Neurology

What Neurologists Can Expect From COVID-19

Newsemia
A discussion with Dr Kenneth Tyler on the most likely neurologic implications of the virus, and how the field can respond to the crisis. Medscape...
Neurology

'Intriguing Changes' in Gut Bacteria After MS Treatment

Newsemia
Significant changes in gut bacteria were observed in patients with multiple sclerosis within a month of treatment with ocrelizumab, a small, ongoing study reports. Medscape...
Pediatrics

Scientists Find Molecular Key to Body Making Healthy T Cells

Newsemia
In a finding that could help lead to new therapies for immune diseases like multiple sclerosis and IBD, scientists report in the Journal of Experimental...
Neurology

Late 30s Could Be 'Critical Time' for Starting MS Therapy

Newsemia
A large study of patients with multiple sclerosis evaluated the interplay of age at disease onset and the timing of immunomodulatory therapy. Medscape Medical News...
Neurology

Unlocking the Mystery of Prodromal MS With a Key Biomarker

Newsemia
The promise of serum neurofilament light chain to diagnose multiple sclerosis continues to evolve, with new evidence supporting a role in identifying presymptomatic disease. Medscape...
Neurology

MESEMS: No Reduction in MS Lesions With Stem Cell Therapy

Newsemia
Although the primary outcome of a multinational phase 2 study was negative, researchers said promising secondary findings support the use of mesenchymal stem cells in...
Neurology

More Evidence for Neurofilament Light Chain as MS Biomarker

Newsemia
Tracking sNfL levels over time corresponds to multiple sclerosis disease course in a longitudinal study, but use of the blood biomarker for individual prognosis remains...
Neurology

FDA OKs Botox for Upper Limb Spasticity in Children

Newsemia
Botox is the first neurotoxin to be approved in the US to treat upper limb spasticity for pediatric patients aged 2 years and older. FDA...
Neurology

ORACLE-MS: Cladribine Effective in MS Subgroups

Newsemia
The recently approved disease-modifying therapy is expected to find a niche for patients with multiple sclerosis who fail other agents. Medscape Medical News Source link...
Neurology

FDA Clears First Soft Robotic Exo-Suit for Stroke Rehab

Newsemia
The ReStore system is designed like a garment that connects to waist pack and cables that help lift the patient’s affected leg in synchronized timing...
Neurology

PREVENT: Eculizumab May Lower Relapse Risk in NMOSD

Newsemia
Use of eculizumab resulted in significantly greater relapse reduction over placebo in patients with neuromyelitis optica spectrum disorder (NMSOD), new findings from the phase 3...
Neurology

Let's Hit the Brakes on Escalation-vs-Induction Debate in MS

Newsemia
Dr Stephen Krieger on the flaws inherent in applying a one-size-fits-all approach to a disease as heterogeneous as MS. Medscape Neurology Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy